RU2319505C2 - Очищенные оболочечные белки вируса гепатита с для диагностического и терапевтического применения - Google Patents

Очищенные оболочечные белки вируса гепатита с для диагностического и терапевтического применения Download PDF

Info

Publication number
RU2319505C2
RU2319505C2 RU2004116914/15A RU2004116914A RU2319505C2 RU 2319505 C2 RU2319505 C2 RU 2319505C2 RU 2004116914/15 A RU2004116914/15 A RU 2004116914/15A RU 2004116914 A RU2004116914 A RU 2004116914A RU 2319505 C2 RU2319505 C2 RU 2319505C2
Authority
RU
Russia
Prior art keywords
virus
hepatitis
vaccine composition
antigen
composition against
Prior art date
Application number
RU2004116914/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2004116914A (ru
Inventor
Герт МАРТЕНС (BE)
Герт МАРТЕНС
Эрик ДЕПЛА (BE)
Эрик ДЕПЛА
Фонс БОСМАН (BE)
Фонс БОСМАН
Original Assignee
Иннодженетикс Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иннодженетикс Н.В. filed Critical Иннодженетикс Н.В.
Publication of RU2004116914A publication Critical patent/RU2004116914A/ru
Application granted granted Critical
Publication of RU2319505C2 publication Critical patent/RU2319505C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2004116914/15A 2001-12-18 2002-12-18 Очищенные оболочечные белки вируса гепатита с для диагностического и терапевтического применения RU2319505C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2051001A 2001-12-18 2001-12-18
US10/020,510 2001-12-18
US41835802P 2002-10-16 2002-10-16
US60/418,358 2002-10-16

Publications (2)

Publication Number Publication Date
RU2004116914A RU2004116914A (ru) 2005-04-20
RU2319505C2 true RU2319505C2 (ru) 2008-03-20

Family

ID=26693530

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004116914/15A RU2319505C2 (ru) 2001-12-18 2002-12-18 Очищенные оболочечные белки вируса гепатита с для диагностического и терапевтического применения

Country Status (12)

Country Link
EP (1) EP1461080A2 (fr)
JP (1) JP2005516939A (fr)
KR (1) KR20040076869A (fr)
CN (1) CN1622828A (fr)
AU (1) AU2002361160B2 (fr)
BR (1) BR0215081A (fr)
CA (1) CA2468690A1 (fr)
IL (1) IL162236A0 (fr)
MX (1) MXPA04005891A (fr)
NZ (1) NZ533396A (fr)
RU (1) RU2319505C2 (fr)
WO (1) WO2003051912A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7108855B2 (en) 1998-06-24 2006-09-19 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US7101561B2 (en) 2000-12-01 2006-09-05 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
WO2002085932A2 (fr) 2001-04-24 2002-10-31 Innogenetics N.V. Constructions et methodes relatives a l'expression de proteines d'enveloppe recombinantes du vhc
FR2859221B1 (fr) * 2003-08-28 2005-10-14 Centre Nat Rech Scient Vecteur de co-expression de domaines membranaires de proteines d'enveloppe d'un virus et utilisations
EP1574517A1 (fr) 2004-03-09 2005-09-14 Innogenetics N.V. HCV E1 contenant les ponts disulfure spécifiques
EP1809773B1 (fr) * 2004-10-18 2014-07-16 Globeimmune, Inc. Moyens therapeutiques a base de levure contre l'infection par hepatite c chronique
CN100365124C (zh) * 2005-10-27 2008-01-30 云南大学 一段丙型肝炎病毒特异性cDNA序列的应用
WO2009030872A1 (fr) * 2007-09-07 2009-03-12 Mats Axel Atterdag Persson Matériaux et procédés pour le traitement de l'hépatite c
SI2285408T1 (sl) 2008-06-05 2019-02-28 Ablynx N.V. Aminokislinska zaporedja usmerjena proti proteinom ovojnicam virusa in polipeptidi, ki zaporedja vsebujejo za zdravljenje virusnih bolezni
NZ597314A (en) 2009-06-05 2013-07-26 Ablynx Nv Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections
EP2507262A1 (fr) 2009-11-30 2012-10-10 Ablynx N.V. Séquences d'acides aminés améliorées dirigées contre le virus syncytial respiratoire humain (hrsv) et polypeptides comprenant celles-ci pour la prévention et/ou le traitement d'infections du tractus respiratoire
EP2720716B1 (fr) 2011-06-14 2018-03-21 Globeimmune, Inc. Compositions immunotherapeutiques pour le traitement ou prévention d'une infection par le virus delta de l'hépatite
RU2570553C2 (ru) * 2013-11-20 2015-12-10 Федеральное бюджетное учреждение "Всероссийский научно-исследовательский институт лесоводства и механизации лесного хозяйства (ФБУ ВНИИЛМ) Способ очистки вирусных полиэдров
CN104327170A (zh) * 2014-05-16 2015-02-04 中国疾病预防控制中心病毒病预防控制所 丙型肝炎病毒(hcv)细胞进入抑制肽zte1序列及应用
CN107002079A (zh) 2014-09-17 2017-08-01 衣阿华大学研究基金会 作为免疫调节剂和疫苗组分的病毒rna区段
US20190284230A1 (en) * 2016-09-29 2019-09-19 Macfarlane Burnet Institute For Medical Research And Public Health Limited Assembled glycoproteins
WO2020117760A1 (fr) * 2018-12-03 2020-06-11 Duke University Procédé de purification de nanoparticules et de protéines recombinantes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0992580T3 (da) * 1993-11-04 2005-07-11 Innogenetics Nv Epitoper på human T-celler, som er immundominante for hepatitis C-virus
NZ508797A (en) * 1998-06-24 2004-02-27 Innogenetics N Particles of HCV envelope proteins: use for vaccination

Also Published As

Publication number Publication date
CN1622828A (zh) 2005-06-01
KR20040076869A (ko) 2004-09-03
NZ533396A (en) 2005-04-29
AU2002361160B2 (en) 2008-07-03
EP1461080A2 (fr) 2004-09-29
BR0215081A (pt) 2004-10-19
WO2003051912A9 (fr) 2004-07-15
WO2003051912A3 (fr) 2004-03-04
JP2005516939A (ja) 2005-06-09
CA2468690A1 (fr) 2003-06-26
MXPA04005891A (es) 2004-09-13
AU2002361160A1 (en) 2003-06-30
WO2003051912A2 (fr) 2003-06-26
IL162236A0 (en) 2005-11-20
RU2004116914A (ru) 2005-04-20

Similar Documents

Publication Publication Date Title
RU2319505C2 (ru) Очищенные оболочечные белки вируса гепатита с для диагностического и терапевтического применения
Yuan et al. Immunization with a pentameric L1 fusion protein protects against papillomavirus infection
McAleer et al. Human hepatitis B vaccine from recombinant yeast
ATE125821T1 (de) Vakzin gegen hepatitis b.
JP2009102327A (ja) パピローマウイルス様粒子、融合タンパク質並びにそれらの製造方法
ATE302795T1 (de) Sich selbst-zusammenbauende rekombinante hpv16 papillomavirus hüllproteine
BR0207067A (pt) Método para identificar, isolar e produzir antìgenos para um patógeno especìfico e uso do mesmo
JP2005525085A5 (fr)
BR0312474A (pt) Partìcula viral adjuvante
US8293528B2 (en) Peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus
WO2001016163A3 (fr) Melange peptidique et vaccin contre une infection virale chronique
DE69533067D1 (de) Hepatis e-virus antigene und dessen verwendungen
RU2000111496A (ru) Новые цирковирусы свиней, вакцины и реагенты для диагностики
FI113621B (fi) Menetelmä rekombinanttiadenovirusrokotteiden valmistamiseksi
NO971529D0 (no) Rekombinante proteiner av en Pakistani stamme av hepatitt E og deres anvendelse i diagnostiske metoder og vaksiner
CN102199217B (zh) 乙型肝炎病毒多表位融合蛋白及其制备方法和应用
RU2313363C2 (ru) Очищенные белки оболочки вируса гепатита с для диагностического и терапевтического применения
DE60232155D1 (de) Humaner rekombinanter antikörper gegen das hepatitis c (hcv) nichtstrukturelles ns3 protein, nukleinsäure und deren verwendungen
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
RU2362586C2 (ru) Фармацевтические композиции для терапевтического применения
CU22642A1 (es) Secuencia de adnc derivadas del genoma del virus de la hepatitis c y su uso
RU2004104357A (ru) Вакцинный состав, потенцированный комбинацией днк и антигена
RU2353651C2 (ru) Рекомбинантные векторы на основе "живого" вируса оспы домашней птицы и их применение в фармацевтических композициях против вируса гепатита с
et Vaccins lmmunogenic forms of inactivated cytokines; used with recombinant HIB virus-1 env peptide and genuine-depleted virus in vaccine against AIDS
AR009855A1 (es) SECUENCIAS NUCLEOTIDICAS DE ADNc DERIVADOS DEL GENOMA DE LA HEPATITIS C, POLINUCLEOTIDOS RECOMBINANTES, MICROORGANISMOS TRANSFORMADOS, SUSTANCIASPROTEINACEAS, MUTLIMEROS PROTEICOS, CRISTALES PROTEICOS Y UNA MOLECULA RECOMBINANTE

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20081219